The partnership between LillyDirect and Walmart allows patients to pick up Zepbound at Walmart pharmacies at the same ...

A rendering of Eli Lilly's planned plant expansion in Pleasant Prairie. The company is preparing for a next phase on a site ...

After filing one lawsuit to try to block Novo Nordisk's $9 billion effort to trump the takeover, Pfizer has returned to the ...

Pfizer filed an antitrust lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for ...

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political ...

AI use cases now run the gamut. From early cancer detection and digital companionship to helping frustrated readers find ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless” ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Tirzepatide, a medication sold under the names Mounjaro for diabetes and Zepbound for weight loss, has shown impressive results in helping people avoid developing diabetes. A new study found that it ...